Epcoritamab in Previously Treated WM

Clinical trial NCT06510491 · RECRUITING

Trial details

NCT number: NCT06510491
Sponsor: Gottfried von Keudell, MD PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom Macroglobulinemia B-Cell Lymphoproliferative Disorder

Start date: 2024-12-06
Primary completion: 2027-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.